| | | | | | | |
 | MODERNA, INC. | -2.18% | 9.39% | -44.02% | -36.22% | 871.24% | 57 385 |
| IQVIA HOLDINGS INC. | -1.99% | 6.76% | -24.79% | -12.81% | 31.89% | 40 468 |
 | LONZA GROUP AG | -0.27% | 4.61% | -32.83% | -23.25% | 55.31% | 39 851 |
 | CELLTRION, INC. | -0.57% | 11.86% | -11.87% | -33.09% | -7.24% | 18 371 |
| ICON PUBLIC LIMITED COMPANY | -0.81% | 6.74% | -29.25% | 1.77% | 42.30% | 17 936 |
| ALNYLAM PHARMACEUTICALS, INC. | -2.93% | 6.86% | -16.15% | -14.44% | 95.98% | 17 820 |
 | PHARMARON BEIJING CO., LTD. | -1.76% | 6.32% | -1.00% | -34.89% | 309.19% | 15 724 |
| BIO-TECHNE CORPORATION | -2.07% | 5.07% | -33.12% | -22.24% | 65.96% | 13 840 |
| HANGZHOU TIGERMED CONSULTING CO., LTD | 2.11% | 12.70% | -13.86% | -43.80% | 114.18% | 12 996 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | -3.54% | 4.28% | -42.27% | -40.58% | 53.28% | 11 498 |
| UNITED THERAPEUTICS CORPORATION | -2.95% | 2.26% | 8.30% | 32.08% | 199.80% | 10 824 |
| QIAGEN N.V. | -0.34% | 8.05% | -15.74% | -5.07% | 15.49% | 10 606 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | 0.28% | -0.40% | 4.80% | 49.67% | 229.80% | 10 215 |
 | GENSCRIPT BIOTECH CORPORATION | -1.41% | 8.97% | -18.84% | -21.46% | 41.84% | 7 708 |
| SYNEOS HEALTH, INC. | -1.99% | 10.53% | -30.40% | -19.10% | 39.89% | 7 397 |
| | | | | | | |
| | Promedio | -1.36% | 6.93% | -20.07% | -14.89% | 143.93% | |
| | Media ponderada por Capi. | -1.44% | 7.15% | -25.31% | -19.67% | 235.75% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Reporte
